These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 20814575)

  • 21. Low titers of serum antibodies inhibiting hemagglutination predict fatal fulminant influenza A(H1N1) 2009 infection.
    Guihot A; Luyt CE; Parrot A; Rousset D; Cavaillon JM; Boutolleau D; Fitting C; Pajanirassa P; Mallet A; Fartoukh M; Agut H; Musset L; Zoorob R; Kirilovksy A; Combadière B; van der Werf S; Autran B; Carcelain G;
    Am J Respir Crit Care Med; 2014 May; 189(10):1240-9. PubMed ID: 24646009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Large Proportion of the Mexican Population Remained Susceptible to A(H1N1)pdm09 Infection One Year after the Emergence of 2009 Influenza Pandemic.
    Veguilla V; López-Gatell H; López-Martínez I; Aparicio-Antonio R; Barrera-Badillo G; Rojo-Medina J; Gross FL; Jefferson SN; Katz JM; Hernández-Ávila M; Alpuche-Aranda CM
    PLoS One; 2016; 11(3):e0150428. PubMed ID: 27003409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serological response to influenza A H1N1 vaccine (Pandemrix®) and seasonal influenza vaccine 2009/2010 in renal transplant recipients and in hemodialysis patients.
    Ott U; Sauerbrei A; Lange J; Schäfler A; Walther M; Wolf G; Wutzler P; Zell R; Krumbholz A
    Med Microbiol Immunol; 2012 Aug; 201(3):297-302. PubMed ID: 22350187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of sample collection tube method, anticoagulant-containing plasma versus serum, on influenza virus hemagglutination inhibition titer and microneutralization titer serological assays.
    Morrison BJ; Martin NJ; Rehman T; Ewing D; Dewar RL; Metcalf J; Sun P; Beigel J; Luke TC; Raviprakash K
    BMC Health Serv Res; 2018 Aug; 18(1):651. PubMed ID: 30134892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical trial to evaluate the safety and immunogenicity of a trivalent surface antigen seasonal influenza vaccine produced in mammalian cell culture and administered to young and elderly adults with and without A(H1N1) pre-vaccination.
    Loebermann M; Voss U; Meyer S; Bosse D; Fritzsche C; Klammt S; Frimmel S; Riebold D; Reisinger EC
    PLoS One; 2013; 8(8):e70866. PubMed ID: 23976960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Analysis of hemagglutination inhibition antibody level in patients with influenza A H1N1].
    Shen HH; Hou J; Zhao M; Xu J; Bai BK; Zhao J; Hu Y; Mao PY; Li BA; Mao YL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Aug; 26(4):270-2. PubMed ID: 23189841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sensitivity and specificity of serologic assays for detection of human infection with 2009 pandemic H1N1 virus in U.S. populations.
    Veguilla V; Hancock K; Schiffer J; Gargiullo P; Lu X; Aranio D; Branch A; Dong L; Holiday C; Liu F; Steward-Clark E; Sun H; Tsang B; Wang D; Whaley M; Bai Y; Cronin L; Browning P; Dababneh H; Noland H; Thomas L; Foster L; Quinn CP; Soroka SD; Katz JM
    J Clin Microbiol; 2011 Jun; 49(6):2210-5. PubMed ID: 21471339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantifying homologous and heterologous antibody titre rises after influenza virus infection.
    Freeman G; Perera RA; Ngan E; Fang VJ; Cauchemez S; Ip DK; Peiris JS; Cowling BJ
    Epidemiol Infect; 2016 Aug; 144(11):2306-16. PubMed ID: 27018720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seroconversion to seasonal influenza viruses after A(H1N1)pdm09 virus infection, Quebec, Canada.
    Baz M; Papenburg J; Hamelin ME; Ouakki M; Skowronski DM; De Serres G; Boivin G
    Emerg Infect Dis; 2012 Jul; 18(7):1132-4. PubMed ID: 22710312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of serum neutralization antibodies against seasonal influenza A strain H3N2 and the emerging strains 2009 H1N1 and avian H5N1.
    Zhang R; Rong X; Pan W; Peng T
    Scand J Infect Dis; 2011 Mar; 43(3):216-20. PubMed ID: 21142624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A survey of levels of antibodies against influenza viruses in the population of Wuxi City].
    You FX; Sun N; Ma GY; Wang MM; Sa D; Shi C; Wu JL; Lin X; Xiao Y; Qian YH; Jiang Y; Xie J; Ji YY; Guan HX
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Oct; 25(5):351-4. PubMed ID: 22338222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythrocyte binding preference of human pandemic influenza virus a and its effect on antibody response detection.
    Makkoch J; Prachayangprecha S; Payungporn S; Chieochansin T; Songserm T; Amonsin A; Poovorawan Y
    Ann Lab Med; 2012 Jul; 32(4):276-82. PubMed ID: 22779069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross-reactive antibody response to the pandemic A (H1N1) 2009 influenza virus induced by vaccination with a seasonal trivalent influenza vaccine: a longitudinal study of three influenza seasons in Japan.
    Uno S; Kimachi K; Matsuo F; Miyazaki K; Oohama A; Kei J; Nishimura T; Odoh K; Kino Y
    Microbiol Immunol; 2012 Dec; 56(12):810-6. PubMed ID: 23009167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seroconversion and asymptomatic infections during oseltamivir prophylaxis against Influenza A H1N1 2009.
    Lee VJ; Yap J; Tay JK; Barr I; Gao Q; Ho HJ; Tan BH; Kelly PM; Tambyah PA; Kelso A; Chen MI
    BMC Infect Dis; 2010 Jun; 10():164. PubMed ID: 20537158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of antibodies to swine influenza viruses in humans with occupational exposure to pigs, Thuringia, Germany, 2008-2009.
    Krumbholz A; Lange J; Dürrwald R; Hoyer H; Bengsch S; Wutzler P; Zell R
    J Med Virol; 2010 Sep; 82(9):1617-25. PubMed ID: 20648619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Profiles of influenza A/H1N1 vaccine response using hemagglutination-inhibition titers.
    Jacobson RM; Grill DE; Oberg AL; Tosh PK; Ovsyannikova IG; Poland GA
    Hum Vaccin Immunother; 2015; 11(4):961-9. PubMed ID: 25835513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between Haemagglutination inhibiting antibodies and protection against clade 6B viruses in 2013 and 2015.
    Ng S; Saborio S; Kuan G; Gresh L; Sanchez N; Ojeda S; Harris E; Balmaseda A; Gordon A
    Vaccine; 2017 Oct; 35(45):6202-6207. PubMed ID: 28986036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poor immune response to a standard single dose non-adjuvanted vaccination against 2009 pandemic H1N1 influenza virus A in the adult and elder hemodialysis patients.
    Chang YT; Guo CY; Tsai MS; Cheng YY; Lin MT; Chen CH; Shen D; Wang JR; Sung JM
    Vaccine; 2012 Jul; 30(33):5009-18. PubMed ID: 22658967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterologous Immune Responses to Influenza Vaccine in Kidney Transplant Recipients.
    Kumar D; Ferreira VH; Campbell P; Hoschler K; Humar A
    Am J Transplant; 2017 Jan; 17(1):281-286. PubMed ID: 27402204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination of serum antibodies against swine-origin influenza A virus H1N1/09 by immunofluorescence, haemagglutination inhibition, and by neutralization tests: how is the prevalence rate of protecting antibodies in humans?
    Allwinn R; Geiler J; Berger A; Cinatl J; Doerr HW
    Med Microbiol Immunol; 2010 May; 199(2):117-21. PubMed ID: 20162304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.